A Feasibility Study of Xofluza Treatment of Influenza in Pediatric Transplant Recipients, Waitlisted Subjects and Household Members After Early Infection Alerting Using Wearable Devices
Latest Information Update: 10 Feb 2025
At a glance
- Drugs Baloxavir-marboxil (Primary)
- Indications Influenza A virus infections; Influenza B virus infections
- Focus Therapeutic Use
Most Recent Events
- 26 Aug 2024 Planned End Date changed from 31 May 2024 to 30 Apr 2025.
- 26 Aug 2024 Planned primary completion date changed from 31 May 2024 to 30 Apr 2025.
- 11 Dec 2023 New trial record